-
Sep 21, 2026Whole-Body Biodistribution Imaging in NHPs | 125I SPECTLearn how 125I molecular imaging enables longitudinal whole-body biodistribution assessment and organ-level drug distribution analysis in NHP studies. -
Aug 21, 2026From Video To Data: 3D AI Tracking For NHP BehaviorLearn how markerless 3D AI tracking converts NHP video into quantitative behavioral endpoints for CNS, pain, pruritus, and translational drug research. -
Jul 23, 2026AI-Powered 3D NHP Behavioral Analysis | Markerless Behavioral PhenotypingDiscover how AI-powered markerless 3D behavioral analysis improves non-human primate behavioral phenotyping for CNS research, translational neuroscience, and preclinical drug de... -
Jul 21, 2026Global Webinar | Quantifying Complex NHP Behaviors: Introducing NHP BehaviorA...In non-human primate (NHP) preclinical research, behavioral endpoints serve as vital indicators that closely bridge drug efficacy to clinical phenotypes. However, in routine stu... -
Jul 17, 2026AI-Powered NHP Behavioral Analysis For Preclinical Drug Development | Prisys ...Discover how Prisys Biotech combines AI-powered 3D markerless motion capture, digital phenotyping, and behavioral analytics to generate objective behavioral endpoints for non-hu... -
Jun 12, 2026Why NHP Molecular Imaging Is Critical For Translational PET StudiesDiscover why non-human primates are essential for translational molecular imaging, PET tracer development, CNS drug research, and radiopharmaceutical evaluation. -
Jun 10, 2026What Is Molecular Imaging And Why Is It Important in Drug Development?Learn how molecular imaging enables non-invasive visualization of biological processes in vivo and supports translational drug development through longitudinal assessment and bi... -
Jun 05, 2026NHP Radionuclide Biodistribution Studies: Molecular Imaging For Translational...Explore how PET-CT, SPECT, and radionuclide molecular imaging in non-human primates (NHPs) are advancing biodistribution, target engagement, and translational evaluation of anti... -
Jun 02, 2026NHP Heart Failure Model Supports Translational Research On Telomere Restorati...Learn how Prisys Biotechnologies' non-human primate heart failure model contributed to a landmark eBioMedicine study validating telomere restoration gene therapy and advancing c... -
May 29, 2026How DSA And CTA Imaging Improve Cardiovascular Drug Safety EvaluationExplore how DSA and CTA imaging technologies support cardiovascular drug safety evaluation, interventional research, and translational preclinical studies. -
May 27, 2026NHP Arteriovenous Shunt Thrombosis Model in Cynomolgus Monkeys For Translatio...Explore Prisys Biotechnologies’ cynomolgus monkey AV shunt thrombosis model for translational evaluation of anticoagulants, FXI inhibitors, and bleeding risk. -
May 15, 2026Non-Human Primate Models Of Pulmonary Fibrosis: Advancing Translational Accur...Explore advanced NHP models for pulmonary fibrosis. Prisys Biotech offers quantitative CT imaging, bronchoscopy-guided dosing, and clinical-grade lung function analysis for biop...
